Shortage updates for Vyvanse (lisdexamfetamine dimesilate) capsules

Takeda Pharmaceuticals Australia has notified us that the shortage of Vyvanse 50 mg capsules has resolved, and that due to manufacturing issues the shortage of Vyvanse 30 mg has been extended until 31 March 2024.

The most up-to-date information about these shortages is published on the Medicine Shortage Reports Database. 

Important information for patients, carers, pharmacists and prescribers is available at About the shortage of Vyvanse (lisdexamfetamine dimesilate) capsules.